Skip to Content

GSI 510 (Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg)

Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide

Pill with imprint GSI 510 is Green, Capsule-shape and has been identified as Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg. It is supplied by Gilead Sciences, Inc..

Genvoya is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 510

Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510
Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510
Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510

Genvoya

Generic Name:
cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide
Imprint:
GSI 510
Strength:
cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-1901

Get help with Imprint Code FAQs.

More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)

Consumer resources

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide